Wilms Tumour

Gene: PALB2

Green List (high evidence)

PALB2 (partner and localizer of BRCA2)
EnsemblGeneIds (GRCh38): ENSG00000083093
EnsemblGeneIds (GRCh37): ENSG00000083093
OMIM: 610355, ClinGen, DECIPHER
PALB2 is in 19 panels

1 review

Chirag Patel (Genetic Health Queensland)

Green List (high evidence)

ClinGen definitive. Wilms tumour reported in condition.
Sources: Expert list, Expert Review
Created: 26 Sep 2024, 10:50 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Wilms tumor, MONDO:0006058; Fanconi anemia complementation group N, MONDO:0012565; Fanconi anemia, complementation group N, MIM#610832

Details

History Filter Activity

9 Oct 2024, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: palb2 has been classified as Green List (High Evidence).

26 Sep 2024, Gel status: 3

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: palb2 has been classified as Green List (High Evidence).

26 Sep 2024, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Chirag Patel (Genetic Health Queensland)

gene: PALB2 was added gene: PALB2 was added to Wilms Tumour. Sources: Expert list,Expert Review Mode of inheritance for gene: PALB2 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: PALB2 were set to Wilms tumor, MONDO:0006058; Fanconi anemia complementation group N, MONDO:0012565; Fanconi anemia, complementation group N, MIM#610832 Review for gene: PALB2 was set to GREEN